Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: A phase II study

R Lord; S Nair; A Schache; J Spicer; N Somaihah; V Khoo; H Pandha

doi:10.1016/j.juro.2007.01.143

Back

Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: A phase II study

Journal article

Open access

Peer reviewed

Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: A phase II study

R Lord, S Nair, A Schache, J Spicer, N Somaihah, V Khoo and H Pandha

JOURNAL OF UROLOGY, Vol.177(6), pp.2136-2140

01/06/2007

DOI: https://doi.org/10.1016/j.juro.2007.01.143

Abstract

Science & Technology

Life Sciences & Biomedicine

Urology & Nephrology

UROLOGY & NEPHROLOGY

cyclophosphamide

prostatic neoplasms

TUMOR-GROWTH

ANGIOGENESIS

CHEMOTHERAPY

MICE

Files and links (3)

pdf

131106_oral_cycloj_urol4103.77 kBDownload View

Text Open Access

url

http://dx.doi.org/10.1016/j.juro.2007.01.143View

Published (Version of record)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000246635800027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

Details

Title: Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: A phase II study
Creators: R Lord
S Nair
A Schache
J Spicer
N Somaihah
V Khoo
H Pandha
Publication Details: JOURNAL OF UROLOGY, Vol.177(6), pp.2136-2140
Publisher: ELSEVIER SCIENCE INC
Publication Date: 01/06/2007
Identifiers: 99514501702346; WOS:000246635800027
Academic Unit: School of Biosciences
Language: English
Resource Type: Journal article

Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: A phase II study

Abstract

Files and links (3)

Metrics

Details

Usage Policy